#BEGIN_DRUGCARD DB03419

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
66-22-8

# ChEBI_ID:
17568

# Chemical_Formula:
C4H4N2O2

# Chemical_IUPAC_Name:
1,2,3,4-tetrahydropyrimidine-2,4-dione

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
-5.37

# Experimental_LogP_Hydrophobicity:
-1.07

# Experimental_Logs:
-1.48

# Experimental_Water_Solubility:
3600 mg/L (at 25 °C)

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Uracil

# HET_ID:
URA

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C4H4N2O2/c7-3-1-2-5-4(8)6-3/h1-2H,(H2,5,6,7,8)

# InChI_Key:
InChIKey=ISAKRJDGNUQOIC-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C00106

# KEGG_Drug_ID:
D00027

# LIMS_Drug_ID:
3419

# Mechanism_Of_Action:
Not Available

# Melting_Point:
338 °C

# Molecular_Weight_Avg:
112.0868

# Molecular_Weight_Mono:
112.027277382

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1WS3

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.2

# Predicted_LogS:
-0.63

# Predicted_Water_Solubility:
2.65e+01 g/l

# Primary_Accession_No:
DB03419

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
1174

# PubChem_Substance_ID:
46504697

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT03201

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
O=C1NC=CC(=O)N1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:14 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
9.45

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
U00008

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
rsuA

# Drug_Target_1_Gene_Sequence:
Not Available

# Drug_Target_1_General_Function:
Translation, ribosomal structure and biogenesis

# Drug_Target_1_General_References:
10376875	Conrad J, Niu L, Rudd K, Lane BG, Ofengand J: 16S ribosomal RNA pseudouridine synthase RsuA of Escherichia coli: deletion, mutation of the conserved Asp102 residue, and sequence comparison among all other pseudouridine synthases. RNA. 1999 Jun;5(6):751-63.
11953756	Sivaraman J, Sauve V, Larocque R, Stura EA, Schrag JD, Cygler M, Matte A: Structure of the 16S rRNA pseudouridine synthase RsuA bound to uracil and UMP. Nat Struct Biol. 2002 May;9(5):353-8.
7612632	Wrzesinski J, Bakin A, Nurse K, Lane BG, Ofengand J: Purification, cloning, and properties of the 16S RNA pseudouridine 516 synthase from Escherichia coli. Biochemistry. 1995 Jul 11;34(27):8904-13.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3706

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
25866

# Drug_Target_1_Name:
Ribosomal small subunit pseudouridine synthase A

# Drug_Target_1_Number_of_Residues:
231

# Drug_Target_1_PDB_ID:
1KSV

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00849	PseudoU_synth_2
PF01479	S4

# Drug_Target_1_Protein_Sequence:
>Ribosomal small subunit pseudouridine synthase A
MRLDKFIAQQLGVSRAIAGREIRGNRVTVDGEIVRNAAFKLLPEHDVAYDGNPLAQQHGP
RYFMLNKPQGYVCSTDDPDHPTVLYFLDEPVAWKLHAAGRLDIDTTGLVLMTDDGQWSHR
ITSPRHHCEKTYLVTLESPVADDTAEQFAKGVQLHNEKDLTKPAVLEVITPTQVRLTISE
GRYHQVKRMFAAVGNHVVELHRERIGGITLDADLAPGEYRPLTEEEIASVV

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Responsible for synthesis of pseudouridine from uracil- 516 in 16S ribosomal RNA

# Drug_Target_1_SwissProt_ID:
P0AA43

# Drug_Target_1_SwissProt_Name:
RSUA_ECOLI

# Drug_Target_1_Synonyms:
16S pseudouridine 516 synthase
16S pseudouridylate 516 synthase
EC 5.4.99.-
rRNA pseudouridylate synthase A
rRNA- uridine isomerase A

# Drug_Target_1_Theoretical_pI:
6.12

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasmic

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
X14112

# Drug_Target_2_GenBank_ID_Protein:
59502

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
UL2

# Drug_Target_2_Gene_Sequence:
>1005 bp
ATGAAGCGGGCCTGCAGCCGAAGCCCCTCACCACGCCGCCGCCCATCATCGCCACGTCGG
ACCCCACCCCGCGACGGGACGCCGCCACAAAAAGCAGACGCCGACGACCCCACTCCCGGC
GCCTCTAACGATGCCTCGACGGAAACCCGTCCGGGTTCGGGGGGCGAACCGGCCGCCTGT
CGCTCGTCAGGGCCGGCGGCGCTCCTCGCCGCCCTAGAGGCTGGTCCCGCTGGTGTGACG
TTTTCCTCGTCCGCGCCCCCCGACCCTCCCATGGATTTAACAAACGGGGGGGTGTCGCCT
GCGGCGACCTCGGCGCCTCTGGACTGGACCACGTTTCGGCGTGTGTTTCTGATCGACGAC
GCGTGGCGGCCCCTGATGGAGCCTGAGCTGGCGAACCCCTTAACCGCCCACCTCCTGGCC
GAATATAATCGTCGGTGCCAGACCGAAGAGGTGCTGCCGCCGCGGGAGGATGTGTTTTCG
TGGACTCGTTATTGCACCCCCGACGAGGTGCGCGTGGTTATCATCGGCCAGGACCCATAT
CACCACCCCGGCCAGGCGCACGGACTTGCGTTTAGCGTGCGCGCGAACGTGCCGCCTCCC
CCGAGTCTTCGGAATGTCTTGGCGGCCGTCAAGAACTGTTATCCCGAGGCACGGATGAGC
GGCCACGGTTGCCTGGAAAAGTGGGCGCGGGACGGCGTCCTGTTACTAAACACGACCCTG
ACCGTCAAGCGCGGGGCGGCGGCGTCCCACTCTAGAATCGGTTGGGACCGTTTCGTGGGC
GGAGTTATCCGCCGGTTGGCCGCGCGCCGCCCCGGCCTGGTGTTTATGCTCTGGGGCACA
CACGCCCAGAATGCCATCAGGCCGGACCCTCGGGTCCATTGCGTCCTCAAGTTTTCGCAC
CCGTCGCCCCTCTCCAAGGTTCCGTTCGGAACCTGCCAGCATTTCCTCGTGGCGAACCGA
TACCTCGAGACCCGGTCGATTTCACCCATCGACTGGTCGGTTTGA

# Drug_Target_2_General_Function:
Coenzyme transport and metabolism

# Drug_Target_2_General_References:
2839594	McGeoch DJ, Dalrymple MA, Davison AJ, Dolan A, Frame MC, McNab D, Perry LJ, Scott JE, Taylor P: The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol. 1988 Jul;69 ( Pt 7):1531-74.
7845459	Savva R, McAuley-Hecht K, Brown T, Pearl L: The structural basis of specific base-excision repair by uracil-DNA glycosylase. Nature. 1995 Feb 9;373(6514):487-93.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
3496

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
36329

# Drug_Target_2_Name:
Uracil-DNA glycosylase

# Drug_Target_2_Number_of_Residues:
334

# Drug_Target_2_PDB_ID:
1LAU

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF03167	UDG

# Drug_Target_2_Protein_Sequence:
>Uracil-DNA glycosylase
MKRACSRSPSPRRRPSSPRRTPPRDGTPPQKADADDPTPGASNDASTETRPGSGGEPAAC
RSSGPAALLAALEAGPAGVTFSSSAPPDPPMDLTNGGVSPAATSAPLDWTTFRRVFLIDD
AWRPLMEPELANPLTAHLLAEYNRRCQTEEVLPPREDVFSWTRYCTPDEVRVVIIGQDPY
HHPGQAHGLAFSVRANVPPPPSLRNVLAAVKNCYPEARMSGHGCLEKWARDGVLLLNTTL
TVKRGAAASHSRIGWDRFVGGVIRRLAARRPGLVFMLWGTHAQNAIRPDPRVHCVLKFSH
PSPLSKVPFGTCQHFLVANRYLETRSISPIDWSV

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Excises uracil residues from the DNA which can arise as a result of misincorporation of dUMP residues by DNA polymerase or due to deamination of cytosine

# Drug_Target_2_SwissProt_ID:
P10186

# Drug_Target_2_SwissProt_Name:
UNG_HHV11

# Drug_Target_2_Synonyms:
EC 3.2.2.-
UDG

# Drug_Target_2_Theoretical_pI:
9.61

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Cytoplasm

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
AE005174

# Drug_Target_3_GenBank_ID_Protein:
12517001

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
ung

# Drug_Target_3_Gene_Sequence:
>690 bp
ATGGCTAACGAATTAACCTGGCATGACGTGCTGGCTGAAGAGAAGCAGCAACCCTATTTT
CTTAATACCCTTCAGACCGTCGCCAGCGAGCGGCAGTCCGGCGTCACTATCTATCCACCA
CAAAAAGATGTCTTTAACGCGTTCCGCTTTACCGAGTTGGGTGACGTTAAAGTGGTGATT
CTCGGCCAGGATCCTTATCACGGACCGGGACAGGCGCATGGGCTGGCATTTTCCGTTCGC
CCCGGAATCGCCACTCCTCCGTCACTGCTGAATATGTATAAAGAGCTGGAAAATACTATT
CCGGGCTTCACCCGCCCTAATCATGGTTATCTTGAAAGCTGGGCGCGTCAGGGCGTTCTG
CTACTCAATACTGTGTTGACGGTACGCGCAGGTCAGGCGCATTCCCACGCCAGCCTCGGC
TGGGAAACCTTCACCGATAAAGTGATCAGCCTGATTAACCAGCATCGCGAAGGCGTGGTG
TTTTTGTTGTGGGGATCGCATGCGCAAAAGAAAGGGGCGATTATAGATAAGCAACGCCAT
CATGTACTGAAAGCACCGCATCCGTCGCCGCTTTCGGCTCATCGTGGATTCTTTGGCTGC
AACCATTTTGTGCTGGCAAATCAGTGGCTGGAACAACATGGCGAGACGCCGATTGACTGG
ATGCCAGTATTACCGGCAGAGAGTGAGTAA

# Drug_Target_3_General_Function:
Replication, recombination and repair

# Drug_Target_3_General_References:
11206551	Perna NT, Plunkett G 3rd, Burland V, Mau B, Glasner JD, Rose DJ, Mayhew GF, Evans PS, Gregor J, Kirkpatrick HA, Posfai G, Hackett J, Klink S, Boutin A, Shao Y, Miller L, Grotbeck EJ, Davis NW, Lim A, Dimalanta ET, Potamousis KD, Apodaca J, Anantharaman TS, Lin J, Yen G, Schwartz DC, Welch RA, Blattner FR: Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature. 2001 Jan 25;409(6819):529-33.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
3512

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
25662

# Drug_Target_3_Name:
Uracil-DNA glycosylase

# Drug_Target_3_Number_of_Residues:
229

# Drug_Target_3_PDB_ID:
1EUG

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF03167	UDG

# Drug_Target_3_Protein_Sequence:
>Uracil-DNA glycosylase
MANELTWHDVLAEEKQQPYFLNTLQTVASERQSGVTIYPPQKDVFNAFRFTELGDVKVVI
LGQDPYHGPGQAHGLAFSVRPGIATPPSLLNMYKELENTIPGFTRPNHGYLESWARQGVL
LLNTVLTVRAGQAHSHASLGWETFTDKVISLINQHREGVVFLLWGSHAQKKGAIIDKQRH
HVLKAPHPSPLSAHRGFFGCNHFVLANQWLEQHGETPIDWMPVLPAESE

# Drug_Target_3_Reaction:
Not Available

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Excises uracil residues from the DNA which can arise as a result of misincorporation of dUMP residues by DNA polymerase or due to deamination of cytosine

# Drug_Target_3_SwissProt_ID:
Q8X444

# Drug_Target_3_SwissProt_Name:
UNG_ECO57

# Drug_Target_3_Synonyms:
EC 3.2.2.-
UDG

# Drug_Target_3_Theoretical_pI:
7.06

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Cytoplasm

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
DPYD

# Drug_Target_4_GenBank_ID_Gene:
U09178

# Drug_Target_4_GenBank_ID_Protein:
558305

# Drug_Target_4_GeneCard_ID:
DPYD

# Drug_Target_4_Gene_Name:
DPYD

# Drug_Target_4_Gene_Sequence:
>3078 bp
ATGGCCCCTGTGCTCAGTAAGGACTCGGCGGACATCGAGAGTATCCTGGCTTTAAATCCT
CGAACACAAACTCATGCAACTCTGTGTTCCACTTCGGCCAAGAAATTAGACAAGAAACAT
TGGAAAAGAAATCCTGATAAGAACTGCTTTAATTGTGAGAAGCTGGAGAATAATTTTGAT
GACATCAAGCACACGACTCTTGGTGAGCGAGGAGCTCTCCGAGAAGCAATGAGATGCCTG
AAATGTGCAGATGCCCCGTGTCAGAAGAGCTGTCCAACTAATCTTGATATTAAATCATTC
ATCACAAGTATTGCAAACAAGAACTATTATGGAGCTGCTAAGATGATATTTTCTGACAAC
CCACTTGGTCTGACTTGTGGAATGGTATGTCCAACCTCTGATCTATGTGTAGGTGGATGC
AATTTATATGCCACTGAAGAGGGACCCATTAATATTGGTGGATTGCAGCAATTTGCTACT
GAGGTATTCAAAGCAATGAGTATCCCACAGATCAGAAATCCTTCGCTGCCTCCCCCAGAA
AAAATGTCTGAAGCCTATTCTGCAAAGATTGCTCTTTTTGGTGCTGGGCCTGCAAGTATA
AGTTGTGCTTCCTTTTTGGCTCGATTGGGGTACTCTGACATCACTATATTTGAAAAACAA
GAATATGTTGGTGGTTTAAGTACTTCTGAAATTCCTCAGTTCCGGCTGCCGTATGATGTA
GTGAATTTTGAGATTGAGCTAATGAAGGACCTTGGTGTAAAGATAATTTGCGGTAAAAGC
CTTTCAGTGAATGAAATGACTCTTAGCACTTTGAAAGAAAAAGGCTACAAAGCTGCTTTC
ATTGGAATAGGTTTGCCAGAACCCAATAAAGATGCCATCTTCCAAGGCCTGACGCAGGAC
CAGGGGTTTTATACATCCAAAGACTTTTTGCCACTTGTAGCCAAAGGCAGTAAAGCAGGA
ATGTGCGCCTGTCACTCTCCATTGCCATCGATACGGGGAGTCGTGATTGTACTTGGAGCT
GGAGACACTGCCTTCGACTGTGCAACATCTGCTCTACGTTGTGGAGCTCGCCGAGTGTTC
ATCGTCTTCAGAAAAGGCTTTGTTAATATAAGAGCTGTCCCTGAGGAGATGGAGCTTGCT
AAGGAAGAAAAGTGTGAATTTCTGCCATTCCTGTCCCCACGGAAGGTTATAGTAAAAGGT
GGGAGAATTGTTGCTATGCAGTTTGTTCGGACAGAGCAAGATGAAACTGGAAAATGGAAT
GAAGATGAAGATCAGATGGTCCATCTGAAAGCCGATGTGGTCATCAGTGCCTTTGGTTCA
GTTCTGAGTGATCCTAAAGTAAAAGAAGCCTTGAGCCCTATAAAATTTAACAGATGGGGT
CTCCCAGAAGTAGATCCAGAAACTATGCAAACTAGTGAAGCATGGGTATTTGCAGGTGGT
GATGTCGTTGGTTTGGCTAACACTACAGTGGAATCGGTGAATGATGGAAAGCAAGCTTCT
TGGTACATTCACAAATACGTACAGTCACAATATGGAGCTTCCGTTTCTGCCAAGCCTGAA
CTACCCCTCTTTTACACTCCTATTGATCTGGTGGACATTAGTGTAGAAATGGCCGGATTG
AAGTTTATAAATCCTTTTGGTCTTGCTAGCGCAACTCCAGCCACCAGCACATCAATGATT
CGAAGAGCTTTTGAAGCTGGATGGGGTTTTGCCCTCACCAAAACTTTCTCTCTTGATAAG
GACATTGTGACAAATGTTTCCCCCAGAATCATCCGGGGAACCACCTCTGGCCCCATGTAT
GGCCCTGGACAAAGCTCCTTTCTGAATATTGAGCTCATCAGTGAGAAAACGGCTGCATAT
TGGTGTCAAAGTGTCACTGAACTAAAGGCTGACTTCCCAGACAACATTGTGATTGCTAGC
ATTATGTGCAGTTACAATAAAAATGACTGGACGGAACTTGCCAAGAAGTCTGAGGATTCT
GGAGCAGATGCCCTGGAGTTAAATTTATCATGTCCACATGGCATGGGAGAAAGAGGAATG
GGCCTGGCCTGTGGGCAGGATCCAGAGCTGGTGCGGAACATCTGCCGCTGGGTTAGGCAA
GCTGTTCAGATTCCTTTTTTTGCCAAGCTGACCCCAAATGTCACTGATATTGTGAGCATC
GCAAGAGCTGCAAAGGAAGGTGGTGCCAATGGCGTTACAGCCACCAACACTGTCTCAGGT
CTGATGGGATTAAAATCTGATGGCACACCTTGGCCAGCAGTGGGGATTGCAAAGCGAACT
ACATATGGAGGAGTGTCTGGGACAGCAATCAGACCTATTGCTTTGAGAGCTGTGACCTCC
ATTGCTCGTGCTCTGCCTGGATTTCCCATTTTGGCTACTGGTGGAATTGACTCTGCTGAA
AGTGGTCTTCAGTTTCTCCATAGTGGTGCTTCCGTCCTCCAGGTATGCAGTGCCATTCAG
AATCAGGATTTCACTGTGATCGAAGACTACTGCACTGGCCTCAAAGCCCTGCTTTATCTG
AAAAGCATTGAAGAACTACAAGACTGGGATGGACAGAGTCCAGCTACTGTGAGTCACCAG
AAAGGGAAACCAGTTCCACGTATAGCTGAACTCATGGACAAGAAACTGCCAAGTTTTGGA
CCTTATCTGGAACAGCGCAAGAAAATCATAGCAGAAAACAAGATTAGACTGAAAGAACAA
AATGTAGCTTTTTCACCACTTAAGAGAAGCTGTTTTATCCCCAAAAGGCCTATTCCTACC
ATCAAGGATGTAATAGGAAAAGCACTGCAGTACCTTGGAACATTTGGTGAATTGAGCAAC
GTAGAGCAAGTTGTGGCTATGATTGATGAAGAAATGTGTATCAACTGTGGTAAATGCTAC
ATGACCTGTAATGATTCTGGCTACCAGGCTATACAGTTTGATCCAGAAACCCACCTGCCC
ACCATAACCGACACTTGTACAGGCTGTACTCTGTGTCTCAGTGTTTGCCCTATTGTCGAC
TGCATCAAAATGGTTTCCAGGACAACACCTTATGAACCAAAGAGAGGCGTACCCTTATCT
GTGAATCCGGTGTGTTAA

# Drug_Target_4_General_Function:
Amino acid transport and metabolism

# Drug_Target_4_General_References:
1512248	Lu ZH, Zhang R, Diasio RB: Purification and characterization of dihydropyrimidine dehydrogenase from human liver. J Biol Chem. 1992 Aug 25;267(24):17102-9.
8083224	Yokota H, Fernandez-Salguero P, Furuya H, Lin K, McBride OW, Podschun B, Schnackerz KD, Gonzalez FJ: cDNA cloning and chromosome mapping of human dihydropyrimidine dehydrogenase, an enzyme associated with 5-fluorouracil toxicity and congenital thymine uraciluria. J Biol Chem. 1994 Sep 16;269(37):23192-6.
8892022	Vreken P, Van Kuilenburg AB, Meinsma R, Smit GP, Bakker HD, De Abreu RA, van Gennip AH: A point mutation in an invariant splice donor site leads to exon skipping in two unrelated Dutch patients with dihydropyrimidine dehydrogenase deficiency. J Inherit Metab Dis. 1996;19(5):645-54.
9135003	Johnson MR, Wang K, Tillmanns S, Albin N, Diasio RB: Structural organization of the human dihydropyrimidine dehydrogenase gene. Cancer Res. 1997 May 1;57(9):1660-3.
9170156	Fernandez-Salguero PM, Sapone A, Wei X, Holt JR, Jones S, Idle JR, Gonzalez FJ: Lack of correlation between phenotype and genotype for the polymorphically expressed dihydropyrimidine dehydrogenase in a family of Pakistani origin. Pharmacogenetics. 1997 Apr;7(2):161-3.
9266349	Vreken P, Van Kuilenburg AB, Meinsma R, van Gennip AH: Identification of novel point mutations in the dihydropyrimidine dehydrogenase gene. J Inherit Metab Dis. 1997 Jul;20(3):335-8.
9439663	Vreken P, Van Kuilenburg AB, Meinsma R, van Gennip AH: Dihydropyrimidine dehydrogenase (DPD) deficiency: identification and expression of missense mutations C29R, R886H and R235W. Hum Genet. 1997 Dec;101(3):333-8.
9464498	Ogura K, Nishiyama T, Takubo H, Kato A, Okuda H, Arakawa K, Fukushima M, Nagayama S, Kawaguchi Y, Watabe T: Suicidal inactivation of human dihydropyrimidine dehydrogenase by (E)-5-(2-bromovinyl)uracil derived from the antiviral, sorivudine. Cancer Lett. 1998 Jan 9;122(1-2):107-13.

# Drug_Target_4_HGNC_ID:
HGNC:3012

# Drug_Target_4_HPRD_ID:
02036

# Drug_Target_4_ID:
1302

# Drug_Target_4_Locus:
1p22

# Drug_Target_4_Molecular_Weight:
111375

# Drug_Target_4_Name:
Dihydropyrimidine dehydrogenase [NADP+]

# Drug_Target_4_Number_of_Residues:
1025

# Drug_Target_4_PDB_ID:
1GTE

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF00037	Fer4
PF01180	DHO_dh
PF07992	Pyr_redox_2

# Drug_Target_4_Protein_Sequence:
>Dihydropyrimidine dehydrogenase [NADP+] precursor
MAPVLSKDSADIESILALNPRTQTHATLCSTSAKKLDKKHWKRNPDKNCFNCEKLENNFD
DIKHTTLGERGALREAMRCLKCADAPCQKSCPTNLDIKSFITSIANKNYYGAAKMIFSDN
PLGLTCGMVCPTSDLCVGGCNLYATEEGPINIGGLQQFATEVFKAMSIPQIRNPSLPPPE
KMSEAYSAKIALFGAGPASISCASFLARLGYSDITIFEKQEYVGGLSTSEIPQFRLPYDV
VNFEIELMKDLGVKIICGKSLSVNEMTLSTLKEKGYKAAFIGIGLPEPNKDAIFQGLTQD
QGFYTSKDFLPLVAKGSKAGMCACHSPLPSIRGVVIVLGAGDTAFDCATSALRCGARRVF
IVFRKGFVNIRAVPEEMELAKEEKCEFLPFLSPRKVIVKGGRIVAMQFVRTEQDETGKWN
EDEDQMVHLKADVVISAFGSVLSDPKVKEALSPIKFNRWGLPEVDPETMQTSEAWVFAGG
DVVGLANTTVESVNDGKQASWYIHKYVQSQYGASVSAKPELPLFYTPIDLVDISVEMAGL
KFINPFGLASATPATSTSMIRRAFEAGWGFALTKTFSLDKDIVTNVSPRIIRGTTSGPMY
GPGQSSFLNIELISEKTAAYWCQSVTELKADFPDNIVIASIMCSYNKNDWTELAKKSEDS
GADALELNLSCPHGMGERGMGLACGQDPELVRNICRWVRQAVQIPFFAKLTPNVTDIVSI
ARAAKEGGANGVTATNTVSGLMGLKSDGTPWPAVGIAKRTTYGGVSGTAIRPIALRAVTS
IARALPGFPILATGGIDSAESGLQFLHSGASVLQVCSAIQNQDFTVIEDYCTGLKALLYL
KSIEELQDWDGQSPATVSHQKGKPVPRIAELMDKKLPSFGPYLEQRKKIIAENKIRLKEQ
NVAFSPLKRSCFIPKRPIPTIKDVIGKALQYLGTFGELSNVEQVVAMIDEEMCINCGKCY
MTCNDSGYQAIQFDPETHLPTITDTCTGCTLCLSVCPIVDCIKMVSRTTPYEPKRGVPLS
VNPVC

# Drug_Target_4_Reaction:
5,6-dihydrouracil + NADP+ = uracil + NADPH + H+

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
Involved in pyrimidine base degradation. Catalyzes the reduction of uracil and thymine. Also involved the degradation of the chemotherapeutic drug 5-fluorouracil

# Drug_Target_4_SwissProt_ID:
Q12882

# Drug_Target_4_SwissProt_Name:
DPYD_HUMAN

# Drug_Target_4_Synonyms:
DHPDHase
DPD
Dihydropyrimidine dehydrogenase precursor
Dihydrothymine dehydrogenase
Dihydrouracil dehydrogenase
EC 1.3.1.2

# Drug_Target_4_Theoretical_pI:
7.05

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Not Available

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
Not Available

# Drug_Target_5_GenBank_ID_Protein:
Not Available

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
UCKL1

# Drug_Target_5_Gene_Sequence:
Not Available

# Drug_Target_5_General_Function:
Not Available

# Drug_Target_5_General_References:
Not Available

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
7092

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
Not Available

# Drug_Target_5_Name:
Uridine-cytidine kinase-like 1

# Drug_Target_5_Number_of_Residues:
0

# Drug_Target_5_PDB_ID:
Not Available

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
Not Available

# Drug_Target_5_Protein_Sequence:
Not Available

# Drug_Target_5_Reaction:
Not Available

# Drug_Target_5_Signals:
Not Available

# Drug_Target_5_Specific_Function:
Not Available

# Drug_Target_5_SwissProt_ID:
Q9NWZ5

# Drug_Target_5_SwissProt_Name:
UCKL1_HUMAN

# Drug_Target_5_Synonyms:
Not Available

# Drug_Target_5_Theoretical_pI:
Not Available

# Drug_Target_5_Transmembrane_Regions:
Not Available

# Drug_Target_6_Cellular_Location:
Not Available

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
Not Available

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
Not Available

# Drug_Target_6_GenBank_ID_Gene:
AB109239

# Drug_Target_6_GenBank_ID_Protein:
Not Available

# Drug_Target_6_GeneCard_ID:
Not Available

# Drug_Target_6_Gene_Name:
udg

# Drug_Target_6_Gene_Sequence:
>618 bp
ATGACCCTGGAACTGCTTCAGGCCCAGGCGCAAAACTGCACCGCCTGCCGCCTCATGGAG
GGCCGGACCCGGGTGGTCTTCGGGGAGGGAAACCCGGACGCAAAGCTCATGATCGTGGGG
GAAGGCCCCGGGGAGGAGGAGGACAAGACGGGCCGCCCCTTCGTGGGCAAGGCGGGGCAG
CTTCTAAACCGCATCCTGGAGGCGGCGGGGATCCCCAGGGAGGAGGTCTACATCACCAAC
ATCGTCAAGTGCCGCCCCCCGCAAAACCGCGCCCCCCTTCCCGACGAGGCCAAGATCTGC
ACGGACAAGTGGCTCCTCAAGCAGATTGAGCTCATCGCCCCCCAGATCATCGTCCCCTTG
GGGGCGGTGGCCGCCGAGTTCTTCCTGGGGGAGAAGGTCTCCATCACCAAGGTCCGGGGG
AAGTGGTACGAGTGGCACGGGATCAAGGTCTTCCCCATGTTCCACCCCGCCTACCTCCTC
AGGAACCCGAGCCGGGCCCCGGGAAGCCCCAAGCACCTCACCTGGCTGGACATCCAAGAG
GTCAAGCGGGCCCTGGACGCCCTCCCTCCCAAGGAGCGGCGCCCGGTGAAGGCGGTGAGC
CAGGAGCCCCTCTTCTAA

# Drug_Target_6_General_Function:
Replication, recombination and repair

# Drug_Target_6_General_References:
14556741	Hoseki J, Okamoto A, Masui R, Shibata T, Inoue Y, Yokoyama S, Kuramitsu S: Crystal structure of a family 4 uracil-DNA glycosylase from Thermus thermophilus HB8. J Mol Biol. 2003 Oct 24;333(3):515-26.

# Drug_Target_6_HGNC_ID:
Not Available

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
5257

# Drug_Target_6_Locus:
Not Available

# Drug_Target_6_Molecular_Weight:
22966

# Drug_Target_6_Name:
Uracil-DNA glycosylase

# Drug_Target_6_Number_of_Residues:
205

# Drug_Target_6_PDB_ID:
1UI0

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
PF03167	UDG

# Drug_Target_6_Protein_Sequence:
>Uracil-DNA glycosylase
MTLELLQAQAQNCTACRLMEGRTRVVFGEGNPDAKLMIVGEGPGEEEDKTGRPFVGKAGQ
LLNRILEAAGIPREEVYITNIVKCRPPQNRAPLPDEAKICTDKWLLKQIELIAPQIIVPL
GAVAAEFFLGEKVSITKVRGKWYEWHGIKVFPMFHPAYLLRNPSRAPGSPKHLTWLDIQE
VKRALDALPPKERRPVKAVSQEPLF

# Drug_Target_6_Reaction:
Not Available

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
Not Available

# Drug_Target_6_SwissProt_ID:
Q7WYV4

# Drug_Target_6_SwissProt_Name:
Q7WYV4_THETH

# Drug_Target_6_Synonyms:
Not Available

# Drug_Target_6_Theoretical_pI:
9.25

# Drug_Target_6_Transmembrane_Regions:
None

# Drug_Target_7_Cellular_Location:
Not Available

# Drug_Target_7_Chromosome_Location:
Not Available

# Drug_Target_7_Drug_References:
Not Available

# Drug_Target_7_Essentiality:
Non-Essential

# Drug_Target_7_GenAtlas_ID:
Not Available

# Drug_Target_7_GenBank_ID_Gene:
D87961

# Drug_Target_7_GenBank_ID_Protein:
Not Available

# Drug_Target_7_GeneCard_ID:
Not Available

# Drug_Target_7_Gene_Name:
pdp

# Drug_Target_7_Gene_Sequence:
>1302 bp
ATGAGAATGGTCGATTTAATTGAGAAAAAACGTGATGGTCATGCGTTAACGAAAGAAGAA
ATTCAGTTTATTATTGAAGGTTACACAAAAGGCGATATTCCTGATTATCAAATGAGCGCA
TTAGCGATGGCGATTTTTTTCCGCGGCATGAATGAAGAAGAGACAGCGGAATTGACGATG
GCGATGGTGCATTCAGGCGATACGATCGACCTTTCGCGAATTGAAGGAATTAAAGTAGAC
AAACATTCAACGGGCGGAGTGGGCGATACAACAACGTTAGTGCTTGGCCCTCTTGTCGCC
TCCGTCGGTGTTCCGGTTGCGAAAATGTCTGGGCGCGGCCTTGGACATACGGGTGGAACG
ATCGACAAACTAGAATCGGTGCCAGGTTTTCACGTTGAAATTACGAACGATGAATTTATC
GATCTTGTCAATAAAAATAAAATTGCCGTTGTCGGTCAGTCTGGTAATTTGACGCCAGCG
GACAAAAAGTTGTATGCGCTTCGTGATGTGACGGCAACGGTCAATAGCATTCCGTTAATT
GCCTCATCGATTATGAGCAAAAAAATTGCCGCAGGGGCAGATGCGATCGTACTTGACGTA
AAAACAGGTGTGGGCGCGTTTATGAAAGATTTAAACGATGCAAAAGCATTAGCGAAAGCG
ATGGTCGATATCGGAAATCGGGTTGGGCGTAAAACGATGGCAATTATTTCTGATATGAGC
CAGCCGCTTGGTTATGCCATTGGAAATGCGCTTGAAGTGAAAGAAGCGATTGATACGTTA
AAAGGAGAAGGTCCAGAAGATTTCCAAGAGCTGTGCTTAGTGCTTGGTAGCCACATGGTA
TATTTAGCGGAAAAAGCATCTTCGCTTGAAGAAGCTCGTCATATGTTAGAAAAAGCGATG
AAAGACGGTTCAGCCCTTCAAACATTTAAAACGTTCTTAGCTGCGCAAGGTGGCGATGCA
TCTGTTGTCGATGACCCAAGCAAATTGCCGCAAGCAAAATATATTATTGAACTAGAAGCG
AAAGAAGATGGATACGTATCCGAAATTGTCGCGGATGCGGTCGGAACGGCGGCGATGTGG
CTTGGTGCAGGGCGAGCGACGAAAGAATCAACGATCGATTTAGCTGTCGGTCTCGTGCTT
CGCAAAAAAGTCGGCGATGCGGTGAAAAAAGGTGAATCGCTCGTTACAATTTACAGCAAC
CGTGAACAAGTGGATGATGTAAAACAAAAACTATATGAAAACATTCGTATTTCAGCAACA
CCTGTTCAAGCTCCAACATTAATTTACGATAAAATTTCGTAA

# Drug_Target_7_General_Function:
Involved in transferase activity, transferring glycosyl groups

# Drug_Target_7_General_References:
8987664	Okuyama K, Hamamoto T, Noguchi T, Midorikawa Y: Molecular cloning and expression of the pyrimidine nucleoside phosphorylase gene from Bacillus stearothermophilus TH 6-2. Biosci Biotechnol Biochem. 1996 Oct;60(10):1655-9.
9817849	Pugmire MJ, Ealick SE: The crystal structure of pyrimidine nucleoside phosphorylase in a closed conformation. Structure. 1998 Nov 15;6(11):1467-79.

# Drug_Target_7_HGNC_ID:
Not Available

# Drug_Target_7_HPRD_ID:
Not Available

# Drug_Target_7_ID:
5258

# Drug_Target_7_Locus:
Not Available

# Drug_Target_7_Molecular_Weight:
46333

# Drug_Target_7_Name:
Pyrimidine-nucleoside phosphorylase

# Drug_Target_7_Number_of_Residues:
433

# Drug_Target_7_PDB_ID:
Not Available

# Drug_Target_7_Pathway:
Not Available

# Drug_Target_7_Pfam_Domain_Function:
PF00591	Glycos_transf_3
PF02885	Glycos_trans_3N
PF07831	PYNP_C

# Drug_Target_7_Protein_Sequence:
>Pyrimidine-nucleoside phosphorylase
MRMVDLIEKKRDGHALTKEEIQFIIEGYTKGDIPDYQMSALAMAIFFRGMNEEETAELTM
AMVHSGDTIDLSRIEGIKVDKHSTGGVGDTTTLVLGPLVASVGVPVAKMSGRGLGHTGGT
IDKLESVPGFHVEITNDEFIDLVNKNKIAVVGQSGNLTPADKKLYALRDVTATVNSIPLI
ASSIMSKKIAAGADAIVLDVKTGVGAFMKDLNDAKALAKAMVDIGNRVGRKTMAIISDMS
QPLGYAIGNALEVKEAIDTLKGEGPEDFQELCLVLGSHMVYLAEKASSLEEARHMLEKAM
KDGSALQTFKTFLAAQGGDASVVDDPSKLPQAKYIIELEAKEDGYVSEIVADAVGTAAMW
LGAGRATKESTIDLAVGLVLRKKVGDAVKKGESLVTIYSNREQVDDVKQKLYENIRISAT
PVQAPTLIYDKIS

# Drug_Target_7_Reaction:
Not Available

# Drug_Target_7_Signals:
None

# Drug_Target_7_Specific_Function:
A pyrimidine nucleoside + phosphate = a pyrimidine base + alpha-D-ribose 1-phosphate

# Drug_Target_7_SwissProt_ID:
P77836

# Drug_Target_7_SwissProt_Name:
PDP_GEOSE

# Drug_Target_7_Synonyms:
EC 2.4.2.2
PYNP

# Drug_Target_7_Theoretical_pI:
5.04

# Drug_Target_7_Transmembrane_Regions:
None

#END_DRUGCARD DB03419
